drugset / Trial / NCT06109428
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing abdominoplasty (Cohort 2).
Timeline
- Start
- 2021-10-12
- Primary completion
- 2022-03-29
- Completion
- 2022-04-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 125 mg | — |
| Subject | HTX-011 | Unknown | 400 mg | — |
| Background | Acetaminophen | Small molecule | 1 g | — |
| Background | Ibuprofen | Small molecule | 400 mg | — |
Indications
No indication recorded.